FDA recall record

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial recall — FDA D-0662-2026

Failed Impurities/Degradation Specifications

Class IIclassification
D-0662-2026official record ID
Jul 15, 2026report date

Recall record at a glance

Official recordD-0662-2026
CategoryDrug Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmONESOURCE SPECIALTY PHARMA LIMITED
Report dateJul 15, 2026
Recall initiation dateJun 7, 2026
Quantity4284 vials
LocationBengaluru, N/A, India

Official product description

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Why the product was recalled

Failed Impurities/Degradation Specifications

Distribution information

Nationwide within the United States

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.